Search

Your search keyword '"Taniguchi, Shuichi"' showing total 11 results
Start Over Author "Taniguchi, Shuichi" Publication Year Range This year
11 results on '"Taniguchi, Shuichi"'

2. Long-term lymphocyte subset number reconstitution is unique but comparable between umbilical cord blood and unrelated bone marrow transplantation

Author

Tsumita, Keiko, Takagi, Shinsuke, Asano-Mori, Yuki, Watanabe, Otoya, Shindo, Michiho, Yamaguchi, Kyosuke, Yuasa, Mitsuhiro, Kageyama, Kosei, Kaji, Daisuke, Taya, Yuki, Nishida, Aya, Ishiwata, Kazuya, Yamamoto, Hisashi, Araoka, Hideki, Yamamoto, Go, Makino, Shigeyoshi, Wake, Atsushi, Uchida, Naoyuki, Taniguchi, Shuichi, and Koike, Yukako

Published
2024
Full Text
View/download PDF

6. A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia

Author

Kato, Kana, Takagi, Shinsuke, Takano, Hirofumi, Tsunoda, Shinichi, Watanabe, Otoya, Yamaguchi, Kyosuke, Kageyama, Kosei, Kaji, Daisuke, Taya, Yuki, Nishida, Aya, Ishiwata, Kazuya, Yamamoto, Hisashi, Yamamoto, Go, Asano-Mori, Yuki, Koike, Yukako, Makino, Shigeyoshi, Wake, Atsushi, Taniguchi, Shuichi, and Uchida, Naoyuki

Published
2024
Full Text
View/download PDF

7. Evaluation of the pharmacokinetics of liposomal amphotericin B and analysis of the relationship between pharmacokinetics, efficacy and safety in patients with hematological diseases

Author

Matsumoto, Kana, Takagi, Shinsuke, Asano-Mori, Yuki, Yamaguchi, Kyosuke, Yuasa, Mitsuhiro, Kageyama, Kosei, Kaji, Daisuke, Nishida, Aya, Ishiwata, Kazuya, Yamamoto, Hisashi, Araoka, Hideki, Miyazaki, Yoshitsugu, Uchida, Naoyuki, Taniguchi, Shuichi, and Morita, Kunihiko

Published
2024
Full Text
View/download PDF

8. Lymphocyte Crossmatch Testing or Donor HLA-DP and -DQ Allele Typing Effectiveness in Single Cord Blood Transplantation for Patients With Anti-HLA Antibodies Other Than Against HLA-A, -B, -C, and -DRB1

Author

Osada, Makoto, Yamamoto, Hisashi, Watanabe, Otoya, Yamaguchi, Kyosuke, Kageyama, Kosei, Kaji, Daisuke, Taya, Yuki, Nishida, Aya, Ishiwata, Kazuya, Takagi, Shinsuke, Makino, Shigeyoshi, Asano-Mori, Yuki, Yamamoto, Go, Taniguchi, Shuichi, Wake, Atsushi, and Uchida, Naoyuki

Published
2024
Full Text
View/download PDF

9. Fatal posterior reversible encephalopathy syndrome after blood transfusion in a patient with myelodysplastic syndromes.

Author

Takigawa, Ken, Shima, Takahiro, Kubara, Chiaki, Akamine, Shun, Utsumi, Sae, Yoshino, Teruhiko, Minami, Mariko, Hayashi, Masayasu, Matsuo, Yayoi, Kuriyama, Takuro, Yoneda, Reiko, Taniguchi, Shuichi, and Eto, Tetsuya

Subjects
POSTERIOR leukoencephalopathy syndrome, BLOOD diseases, BLOOD transfusion, MAGNETIC resonance imaging, MYELODYSPLASTIC syndromes, RED blood cell transfusion, HEART failure
Abstract

Background: Posterior reversible encephalopathy syndrome (PRES) is known as a transfusion‐related complication with typically favorable prognosis and no report fatalities. Pathological evaluation of PRES is also scarce. Case Report: An 88‐year‐old female with myelodysplastic syndromes (MDS) attended our hospital because of a compression fracture and chronic heart failure with chronic anemia. While her hemoglobin levels improved from 4.6 to 8.0 g/dL and the pleural effusions substantially decreased following six units of red blood cell transfusion and diuretic therapy, a gradual decline in cognitive function and speech reduction was noted. PRES was diagnosed by magnetic resonance imaging of the head. Despite treatment of intensive supportive care, the patient fell into a coma by the 20th day and passed away on the 22nd day. Although the pathophysiological link between blood‐transfusion‐related PRES and its impact on survival is not fully understood, autopsy findings confirmed the diagnosis of PRES and revealed multiple cerebral hemorrhages that were not detected in earlier imaging studies. Conclusion: This case highlights the importance of vigilant monitoring and management of PRES, especially in high‐risk populations such as elderly patients with multiple comorbidities or those with thrombocytopenia. Further studies are needed to elucidate the mechanisms of PRES in patients with hematologic diseases. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. [Congenital thrombotic thrombocytopenic purpura diagnosed in adulthood after repeated thrombocytopenia since neonatal period].

Author

Yoshino T, Kuriyama T, Utsumi S, Shimakawa T, Minami M, Hayashi M, Matsuo Y, Kokame K, Nakamura E, Matsumoto M, Eto T, and Taniguchi S

Subjects
Adult, Infant, Newborn, Female, Humans, Platelet Count, Plasma, Blood Transfusion, ADAMTS13 Protein genetics, Purpura, Thrombotic Thrombocytopenic diagnosis, Purpura, Thrombotic Thrombocytopenic therapy, Purpura, Thrombocytopenic, Idiopathic
Abstract

A 27-year-old woman was diagnosed with idiopathic thrombocytopenic purpura in the neonatal period, and was admitted to our hospital after presenting with impaired consciousness, purpura, nausea and vomiting, with a platelet count of 10×10 9 /l. Congenital thrombotic thrombocytopenic purpura (cTTP) was suspected on the basis of recurrent thrombocytopenia and impaired consciousness, so tests for ADAMTS13 activity and inhibitor were performed. ADAMTS13 activity was severely decreased, ADAMTS13 inhibitor was negative, and platelet count increased after transfusion of fresh frozen plasma. These findings and the results of genetic testing done on all family members led to a diagnosis of cTTP. cTTP requires differential diagnosis even in adults. If a patient diagnosed with ITP in childhood has a history or findings that suggest cTTP during follow-up observation, it is necessary to actively consider ADAMTS13 testing.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results